Artificial neural network modeling of antimycobacterial chemical space to introduce efficient descriptors employed for drug design
暂无分享,去创建一个
[1] Anders Karlén,et al. Evaluation of the amino acid binding site of Mycobacterium tuberculosis glutamine synthetase for drug discovery. , 2008, Bioorganic & medicinal chemistry.
[2] W. W. Barrow,et al. Anti-HIV natural product (+)-calanolide A is active against both drug-susceptible and drug-resistant strains of Mycobacterium tuberculosis. , 2004, Bioorganic & medicinal chemistry.
[3] Mark J. Schreiber,et al. Peptide deformylase inhibitors of Mycobacterium tuberculosis: synthesis, structural investigations, and biological results. , 2008, Bioorganic & medicinal chemistry letters.
[4] C. Bewley,et al. Design and synthesis of substrate-mimic inhibitors of mycothiol-S-conjugate amidase from Mycobacterium tuberculosis. , 2007, Bioorganic & medicinal chemistry letters.
[5] M. Daffé,et al. Synthesis and evaluation of a novel series of pseudo-cinnamic derivatives as antituberculosis agents. , 2009, Bioorganic & medicinal chemistry letters.
[6] S. Cannas,et al. In vitro activity of new quinoxalin 1,4-dioxide derivatives against strains of Mycobacterium tuberculosis and other mycobacteria. , 2005, International journal of antimicrobial agents.
[7] P. Yogeeswari,et al. An atom economic synthesis and antitubercular evaluation of novel spiro-cyclohexanones. , 2009, Bioorganic & medicinal chemistry letters.
[8] P. Yogeeswari,et al. Synthesis and antimycobacterial activities of novel 6-nitroquinolone-3-carboxylic acids. , 2009, European journal of medicinal chemistry.
[9] M. Everett,et al. Evaluation of N-(phenylmethyl)-4-[5-(phenylmethyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-4-yl]benzamide inhibitors of Mycobacterium tuberculosis growth. , 2007, Bioorganic & medicinal chemistry letters.
[10] H. Drugeon,et al. Comparison of the in vitro activities of rifapentine and rifampicin against Mycobacterium tuberculosis complex. , 2000, The Journal of antimicrobial chemotherapy.
[11] Victor Lobanov,et al. Using artificial neural networks to drive virtual screening of combinatorial libraries , 2004 .
[12] A. Schüffler,et al. Isolation, structure elucidation, and biological evaluation of the unusual heterodimer chrysoxanthone from the ascomycete IBWF11-95A , 2009 .
[13] B. Meibohm,et al. Discovery of novel isoxazolines as anti-tuberculosis agents. , 2007, Bioorganic & medicinal chemistry letters.
[14] N. Lall,et al. Antiviral and antituberculous activity of Helichrysum melanacme constituents. , 2006, Fitoterapia.
[15] C. Townsend,et al. In Vitro Activity of a Novel Antimycobacterial Compound, N-Octanesulfonylacetamide, and Its Effects on Lipid and Mycolic Acid Synthesis , 2001, Antimicrobial Agents and Chemotherapy.
[16] N. Lall,et al. Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp. , 2009, International journal of antimicrobial agents.
[17] L. Gundersen,et al. Synthesis and antimycobacterial activity of 5-formylaminopyrimidines; analogs of antibacterial purines. , 2009, Bioorganic & medicinal chemistry letters.
[18] Perumal Yogeeswari,et al. 5-Nitrofuran-2-yl derivatives: synthesis and inhibitory activities against growing and dormant mycobacterium species. , 2009, Bioorganic & medicinal chemistry letters.
[19] A. Kamal,et al. Antitubercular agents. Part 1: synthesis of phthalimido- and naphthalimido-linked phenazines as new prototype antitubercular agents. , 2005, Bioorganic & medicinal chemistry letters.
[20] F. Vergara,et al. Antitubercular activity of alpha,omega-diaminoalkanes, H2N(CH2)nNH2. , 2009, Bioorganic & medicinal chemistry letters.
[21] Derek S. Tan,et al. Mechanism-based inhibitors of MenE, an acyl-CoA synthetase involved in bacterial menaquinone biosynthesis. , 2008, Bioorganic & medicinal chemistry letters.
[22] K. Srivastava,et al. Substituted quinolinyl chalcones and quinolinyl pyrimidines as a new class of anti-infective agents. , 2009, European journal of medicinal chemistry.
[23] M. Fauville-Dufaux,et al. Antimycobacterial activity of synthetic pamamycins. , 2004, The Journal of antimicrobial chemotherapy.
[24] J. Maugein,et al. Synthesis and antitubercular activity of ferrocenyl diaminoalcohols and diamines. , 2008, Bioorganic & medicinal chemistry.
[25] G. Besra,et al. Platensimycin Activity against Mycobacterial β-Ketoacyl-ACP Synthases , 2009, PloS one.
[26] A. Dimoglo,et al. Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. , 2007, Bioorganic & medicinal chemistry.
[27] Adrian G. Barnett,et al. Cost-Effectiveness of a Telephone-Delivered Intervention for Physical Activity and Diet , 2009, PloS one.
[28] C. Kaiser,et al. Synthesis and in vitro antitubercular activity of a series of quinoline derivatives. , 2009, Bioorganic & medicinal chemistry.
[29] P. Yogeeswari,et al. A microwave-assisted facile regioselective Fischer indole synthesis and antitubercular evaluation of novel 2-aryl-3,4-dihydro-2H-thieno[3,2-b]indoles. , 2009, Bioorganic & medicinal chemistry letters.
[30] Clifton E. Barry,et al. A small-molecule nitroimidazopyran drug candidate for the treatment of tuberculosis , 2000, Nature.
[31] S. Gibbons,et al. Modulation of isoniazid susceptibility by flavonoids in Mycobacterium , 2008 .
[32] D. Sriram,et al. Antimycobacterial and phototoxic evaluation of novel 6-fluoro/nitro-4-oxo-7-(sub)-4H-[1,3]thiazeto[3,2-a]quinoline-3-carboxylic acid. , 2008, International journal of antimicrobial agents.
[33] W. Bishai,et al. Antimycobacterial activity of cerulenin and its effects on lipid biosynthesis. , 1999, The Journal of antimicrobial chemotherapy.
[34] N. Lounis,et al. In Vitro and In Vivo Activities of Moxifloxacin and Clinafloxacin against Mycobacterium tuberculosis , 1998, Antimicrobial Agents and Chemotherapy.
[35] G. Besra,et al. Arabinofuranose disaccharide analogs as inhibitors of Mycobacterium tuberculosis , 2003 .
[36] J. Dimmock,et al. N-Aroyl-3,5-bis(benzylidene)-4-piperidones: a novel class of antimycobacterial agents. , 2008, Bioorganic & medicinal chemistry.
[37] Yves L Janin,et al. Antituberculosis drugs: ten years of research. , 2007, Bioorganic & medicinal chemistry.
[38] S. Franzblau,et al. In Vitro and In Vivo Activities of Macrolide Derivatives against Mycobacterium tuberculosis , 2005, Antimicrobial Agents and Chemotherapy.
[39] S. Dastidar,et al. Antimycobacterial activity of the antiinflammatory agent diclofenac sodium, and its synergism with streptomycin , 2004 .
[40] G. Besra,et al. EthA, a Common Activator of Thiocarbamide-Containing Drugs Acting on Different Mycobacterial Targets , 2007, Antimicrobial Agents and Chemotherapy.
[41] D. Minnikin,et al. Biphenyl-based analogues of thiolactomycin, active against Mycobacterium tuberculosis mtFabH fatty acid condensing enzyme. , 2003, Bioorganic & medicinal chemistry letters.
[42] Joel S. Freundlich,et al. Triclosan Derivatives: Towards Potent Inhibitors of Drug‐Sensitive and Drug‐Resistant Mycobacterium tuberculosis , 2009, ChemMedChem.
[43] M. Cynamon,et al. In Vitro Antimycobacterial Activity of 5-Chloropyrazinamide , 1998, Antimicrobial Agents and Chemotherapy.
[44] P. Madge,et al. Synthesis and biological evaluation of galactofuranosyl alkyl thioglycosides as inhibitors of mycobacteria. , 2007, Carbohydrate research.
[45] Kerly F. M. Pasqualoto,et al. QSAR Modeling of a Set of Pyrazinoate Esters as Antituberculosis Prodrugs , 2010, Archiv der Pharmazie.
[46] D. Sarkar,et al. Bactericidal activity of 2-nitroimidazole against the active replicating stage of Mycobacterium bovis BCG and Mycobacterium tuberculosis with intracellular efficacy in THP-1 macrophages. , 2008, International journal of antimicrobial agents.
[47] F. Baquero,et al. In vitro activity of linezolid against Mycobacterium tuberculosis complex, including multidrug-resistant Mycobacterium bovis isolates. , 2006, International journal of antimicrobial agents.
[48] Dhople Am. In vitro activity of KRM-1648, either singly or in combination with ofloxacin, against Mycobacterium ulcerans. , 2001 .
[49] Mohamed Ashraf Ali,et al. Synthesis and evaluation of phenoxy acetic acid derivatives as anti-mycobacterial agents , 2006 .
[50] Shagufta,et al. Diaryloxy methano phenanthrenes: a new class of antituberculosis agents. , 2004, Bioorganic & medicinal chemistry.
[51] S. Cannas,et al. [1,2,3]Triazolo[4,5-h]quinolones. A new class of potent antitubercular agents against multidrug resistant Mycobacterium tuberculosis strains. , 2007, Bioorganic & medicinal chemistry letters.
[52] M. Radi,et al. Synthesis, biological evaluation, and SAR study of novel pyrazole analogues as inhibitors of Mycobacterium tuberculosis: part 2. Synthesis of rigid pyrazolones. , 2009, Bioorganic & medicinal chemistry.
[53] J. Kočí,et al. Preparation and in vitro evaluation of benzylsulfanyl benzoxazole derivatives as potential antituberculosis agents. , 2009, European journal of medicinal chemistry.
[54] A. Gaikwad,et al. Synthesis and antitubercular activities of bis-glycosylated diamino alcohols. , 2005, Bioorganic & medicinal chemistry.
[55] E. Laurini,et al. Antimycobacterial activity of new 3,5-disubstituted 1,3,4-oxadiazol-2(3H)-one derivatives. Molecular modeling investigations. , 2009, Bioorganic & medicinal chemistry.
[56] C. Townsend,et al. New α-methylene-γ-butyrolactones with antimycobacterial properties , 2005 .
[57] M. Şenel,et al. Synthesis, characterization and antimicrobial activity of water soluble dendritic macromolecules. , 2009, European journal of medicinal chemistry.
[58] S. Maitra,et al. Principle Component Analysis and Partial Least Squares: Two Dimension Reduction Techniques for Regression , 2008 .
[59] Vasyl Kovalishyn,et al. Predictive QSAR modeling of phosphodiesterase 4 inhibitors. , 2012, Journal of molecular graphics & modelling.
[60] Aldo Segura-Cabrera,et al. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening. , 2008, Bioorganic & medicinal chemistry letters.
[61] R. Wallace,,et al. Clinical Trial of Clarithromycin for Cutaneous (Disseminated) Infection due to Mycobacterium chelonae , 1993, Annals of Internal Medicine.
[62] D. Muthas,et al. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors. , 2009, Bioorganic & medicinal chemistry letters.
[63] J. Férriz,et al. New antituberculotics originated from salicylanilides with promising in vitro activity against atypical mycobacterial strains. , 2009, Bioorganic & medicinal chemistry.
[64] Ş. Küçükgüzel,et al. Synthesis, characterization of novel coupling products and 4-arylhydrazono-2-pyrazoline-5-ones as potential antimycobacterial agents. , 2002, Farmaco.
[65] J. Chattopadhyaya,et al. Design, synthesis, biological evaluation and molecular modelling studies of novel quinoline derivatives against Mycobacterium tuberculosis. , 2009, Bioorganic & medicinal chemistry.
[66] A. Gaikwad,et al. Synthesis of galactopyranosyl amino alcohols as a new class of antitubercular and antifungal agents. , 2004, Bioorganic & medicinal chemistry letters.
[67] R. Meleddu,et al. Novel N-aryl- and N-heteryl phenazine-1-carboxamides as potential agents for the treatment of infections sustained by drug-resistant and multidrug-resistant Mycobacterium tuberculosis. , 2009, International journal of antimicrobial agents.
[68] L. M. Lima,et al. Selective activity against Mycobacteriumtuberculosis of new quinoxaline 1,4-di-N-oxides. , 2009, Bioorganic & medicinal chemistry.
[69] Yoshifumi Yamamoto,et al. Synthesis of new sugar derivatives from Stachys sieboldi Miq and antibacterial evaluation against Mycobacterium tuberculosis, Mycobacterium avium, and Staphylococcus aureus. , 2007, Bioorganic & medicinal chemistry letters.
[70] P. Juréen,et al. Discordant Resistance to Kanamycin and Amikacin in Drug-Resistant Mycobacterium tuberculosis , 2003, Antimicrobial Agents and Chemotherapy.
[71] A. V. Adhikari,et al. Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents. , 2010, Bioorganic & medicinal chemistry letters.
[72] S. Franzblau,et al. Structure-activity relationships of macrolides against Mycobacterium tuberculosis. , 2008, Tuberculosis.
[73] A. Misra,et al. Synthesis and evaluation of antitubercular activity of glycosyl thio- and sulfonyl acetamide derivatives. , 2008, Bioorganic & medicinal chemistry letters.
[74] A. Okunade,et al. Natural antimycobacterial metabolites: current status. , 2004, Phytochemistry.
[75] J. Férriz,et al. Salicylanilide esters of N-protected amino acids as novel antimicrobial agents. , 2009, Bioorganic & medicinal chemistry letters.
[76] C. Wagner,et al. Synthesis and evaluation of potential inhibitors of eIF4E cap binding to 7-methyl GTP. , 2005, Bioorganic & medicinal chemistry letters.
[77] A. Fassihi,et al. Synthesis and antitubercular activity of novel 4-substituted imidazolyl-2,6-dimethyl-N3,N5-bisaryl-1,4-dihydropyridine-3,5-dicarboxamides. , 2009, European journal of medicinal chemistry.
[78] The metabolism of 2-methyladenosine in Mycobacterium smegmatis. , 2002, Microbiology.
[79] P. Brennan,et al. N-D-aldopentofuranosyl-N'-[p-(isoamyloxy)phenyl]-thiourea derivatives: potential anti-TB therapeutic agents. , 2008, Bioorganic & medicinal chemistry letters.
[80] D. Ordway,et al. Activity against Mycobacterium tuberculosis with concomitant induction of cellular immune responses by a tetraaza-macrocycle with acetate pendant arms. , 2001, Research in microbiology.
[81] Ping Chen,et al. Identification of a new antitubercular drug candidate, SQ109, from a combinatorial library of 1,2-ethylenediamines. , 2005, The Journal of antimicrobial chemotherapy.
[82] A. Monge,et al. Synthesis of new 2-acetyl and 2-benzoyl quinoxaline 1,4-di-N-oxide derivatives as anti-Mycobacterium tuberculosis agents. , 2003, European journal of medicinal chemistry.
[83] S. Cole,et al. A new synthetic access to furo[3,2-f]chromene analogues of an antimycobacterial. , 2008, Bioorganic & medicinal chemistry.
[84] I. Chopra,et al. Antibacterial spectra of drugs used for chemotherapy of mycobacterial infections. , 1998, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[85] S. Said-Fernández,et al. Synthesis and antimycobacterial activity of 4-(5-substituted-1,3,4-oxadiazol-2-yl)pyridines. , 2007, Bioorganic & medicinal chemistry.
[86] V. Labombardi,et al. Ciprofloxacin susceptibility testing by MIC and disk elution of drug-resistant Mycobacterium tuberculosis and Mycobacterium avium complex , 1993, Antimicrobial Agents and Chemotherapy.
[87] S. Franzblau,et al. Efficacy of Quinoxaline-2-Carboxylate 1,4-Di-N-Oxide Derivatives in Experimental Tuberculosis , 2008, Antimicrobial Agents and Chemotherapy.
[88] A. Gaikwad,et al. Baylis-Hillman reaction: convenient ascending syntheses and biological evaluation of acyclic deoxy monosaccharides as potential antimycobacterial agents. , 2002, Bioorganic & medicinal chemistry.
[89] D. Chanda,et al. Antitubercular potential of some semisynthetic analogues of phytol. , 2010, Bioorganic & medicinal chemistry letters.
[90] J. D. Douglas,et al. Analogues of thiolactomycin: potential drugs with enhanced anti-mycobacterial activity. , 2002, Microbiology.
[91] Dong-Wan Koo,et al. In vitro and ex vivo activity of new derivatives of acetohydroxyacid synthase inhibitors against Mycobacterium tuberculosis and non-tuberculous mycobacteria. , 2008, International journal of antimicrobial agents.
[92] A. Dimoglo,et al. Synthesis of novel 5-aryl-2-thio-1,3,4-oxadiazoles and the study of their structure-anti-mycobacterial activities. , 2005, Bioorganic & medicinal chemistry.
[93] P. Yogeeswari,et al. Gatifloxacin derivatives: synthesis, antimycobacterial activities, and inhibition of Mycobacterium tuberculosis DNA gyrase. , 2006, Bioorganic & medicinal chemistry letters.
[94] Ying Zhang,et al. Activity of ketoconazole against Mycobacterium tuberculosis in vitro and in the mouse model. , 2007, Journal of medical microbiology.
[95] P. Vohra,et al. Cloning and characterization of CYP51 from Mycobacterium avium. , 2006, American journal of respiratory cell and molecular biology.
[96] Ram Sagar,et al. CP-MLR directed QSAR studies on the antimycobacterial activity of functionalized alkenols--topological descriptors in modeling the activity. , 2005, Bioorganic & medicinal chemistry.
[97] J. Naismith,et al. Novel inhibitors of an emerging target in Mycobacterium tuberculosis; substituted thiazolidinones as inhibitors of dTDP-rhamnose synthesis. , 2003, Bioorganic & medicinal chemistry letters.
[98] G. Besra,et al. Design, synthesis, biochemical evaluation and antimycobacterial action of phosphonate inhibitors of antigen 85C, a crucial enzyme involved in biosynthesis of the mycobacterial cell wall. , 2007, European journal of medicinal chemistry.
[99] P. Yogeeswari,et al. Synthesis, in vitro and in vivo antimycobacterial activities of diclofenac acid hydrazones and amides. , 2006, Bioorganic & medicinal chemistry.
[100] H. Munier-Lehmann,et al. Substituted benzyl-pyrimidines targeting thymidine monophosphate kinase of Mycobacterium tuberculosis: synthesis and in vitro anti-mycobacterial activity. , 2008, Bioorganic & medicinal chemistry.
[101] rpoB Gene mutations in rifampin-resistant Mycobacterium tuberculosis identified by polymerase chain reaction single-stranded conformational polymorphism. , 2001, Emerging infectious diseases.
[102] L. Toll,et al. Synthesis and antitubercular activity of phenothiazines with reduced binding to dopamine and serotonin receptors. , 2007, Bioorganic & medicinal chemistry letters.
[103] J. Chattopadhyaya,et al. Design, synthesis and biological evaluation of novel triazole, urea and thiourea derivatives of quinoline against Mycobacterium tuberculosis. , 2009, Bioorganic & medicinal chemistry.
[104] R. Miri,et al. Synthesis and biological evaluation of some new 1,4-dihydropyridines containing different ester substitute and diethyl carbamoyl group as anti-tubercular agents. , 2009, Bioorganic & medicinal chemistry.
[105] R. Wallace,,et al. In Vitro Activities of the Novel Oxazolidinones DA-7867 and DA-7157 against Rapidly and Slowly Growing Mycobacteria , 2006, Antimicrobial Agents and Chemotherapy.
[106] R. Sood,et al. Activity of RBx 7644 and RBx 8700, new investigational oxazolidinones, against Mycobacterium tuberculosis infected murine macrophages. , 2005, International journal of antimicrobial agents.
[107] P. Madge,et al. Synthesis and evaluation of galactofuranosyl N,N-dialkyl sulfenamides and sulfonamides as antimycobacterial agents. , 2007, Bioorganic & medicinal chemistry letters.
[108] Joel S. Freundlich,et al. Computational databases, pathway and cheminformatics tools for tuberculosis drug discovery. , 2011, Trends in Microbiology.
[109] J. Suwiński,et al. Synthesis and anti-tuberculosis activity of N-aryl-C-nitroazoles. , 2004, European journal of medicinal chemistry.
[110] J. Klucik,et al. Novel heteroarotinoids as potential antagonists of Mycobacterium bovis BCG. , 2004, Journal of medicinal chemistry.
[111] Karel Waisser,et al. N‐Benzylsalicylthioamides: Highly Active Potential Antituberculotics , 2009, Archiv der Pharmazie.
[112] N. Sinha,et al. Synthesis of 1-[3-(4-benzotriazol-1/2-yl-3-fluoro-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-3-substituted-thiourea derivatives as antituberculosis agents. , 2006, European journal of medicinal chemistry.
[113] Fabrizio Manetti,et al. Antimycobacterial agents. Novel diarylpyrrole derivatives of BM212 endowed with high activity toward Mycobacterium tuberculosis and low cytotoxicity. , 2006, Journal of medicinal chemistry.
[114] C. Bewley,et al. Inhibition and kinetics of mycobacterium tuberculosis and mycobacterium smegmatis mycothiol-S-conjugate amidase by natural product inhibitors. , 2003, Bioorganic & medicinal chemistry.
[115] R. Ahmad,et al. Synthesis and bioevaluation of glycosyl ureas as alpha-glucosidase inhibitors and their effect on mycobacterium. , 2003, Bioorganic & medicinal chemistry.
[116] A. Lenaerts,et al. Synthesis of new and potent analogues of anti-tuberculosis agent 5-nitro-furan-2-carboxylic acid 4-(4-benzyl-piperazin-1-yl)-benzylamide with improved bioavailability. , 2006, Bioorganic & medicinal chemistry letters.
[117] A. Shafiee,et al. Synthesis and antimycobacterial activity of some alkyl [5-(nitroaryl)-1,3,4-thiadiazol-2-ylthio]propionates. , 2006, Bioorganic & medicinal chemistry letters.
[118] R. Gozalbes,et al. Design, synthesis and activity against Toxoplasma gondii, Plasmodium spp., and Mycobacterium tuberculosis of new 6-fluoroquinolones. , 2006, European journal of medicinal chemistry.
[119] C. Boojamra,et al. Synthetic dihydropacidamycin antibiotics: a modified spectrum of activity for the pacidamycin class. , 2003, Bioorganic & medicinal chemistry letters.
[120] S. Terashima,et al. Synthesis and biological activity of enantiomeric pairs of 5-[(E)-cycloalk-2-enylidenemethyl]thiolactomycin congeners. , 2008, Bioorganic & medicinal chemistry letters.
[121] A. Gaikwad,et al. A facile synthesis of alpha,alpha'-(EE)-bis(benzylidene)-cycloalkanones and their antitubercular evaluations. , 2009, European journal of medicinal chemistry.
[122] A. Calderón,et al. 3-Farnesyl-2-hydroxybenzoic acid is a new anti-Helicobacter pylori compound from Piper multiplinervium. , 2006, Journal of ethnopharmacology.
[123] L. Gundersen,et al. Synthesis of indolizine derivatives with selective antibacterial activity against Mycobacterium tuberculosis. , 2007, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[124] Cristina R Ventura,et al. Application of quantitative structure-activity relationships to the modeling of antitubercular compounds. 1. The hydrazide family. , 2008, Journal of medicinal chemistry.
[125] K. Pupek,et al. Pyranocoumarin, a novel anti-TB pharmacophore: synthesis and biological evaluation against Mycobacterium tuberculosis. , 2006, Bioorganic & medicinal chemistry.
[126] P. Yogeeswari,et al. Synthesis and in vitro antitubercular activity of some 1-[(4-sub)phenyl]-3-(4-{1-[(pyridine-4-carbonyl)hydrazono]ethyl}phenyl)thiourea. , 2006, Bioorganic & medicinal chemistry letters.
[127] W. Denny,et al. A roadmap for drug discovery and its translation to small molecule agents in clinical development for tuberculosis treatment. , 2008, Tuberculosis.
[128] Kerly F. M. Pasqualoto,et al. Fragment-based and classical quantitative structure–activity relationships for a series of hydrazides as antituberculosis agents , 2008, Molecular Diversity.
[129] Roman Rosipal,et al. Overview and Recent Advances in Partial Least Squares , 2005, SLSFS.
[130] M. Matsumoto,et al. OPC-67683, a Nitro-Dihydro-Imidazooxazole Derivative with Promising Action against Tuberculosis In Vitro and In Mice , 2006, PLoS medicine.
[131] I. Sugawara,et al. Cross-resistance of Mycobacterium tuberculosis isolates among streptomycin, kanamycin and amikacin. , 2009, Indian journal of experimental biology.
[132] S. Cole,et al. Synthesis and antimycobacterial evaluation of benzofurobenzopyran analogues. , 2007, Bioorganic & medicinal chemistry.
[133] C. Vilchèze,et al. Pyrazinoic Acid and Its n-Propyl Ester Inhibit Fatty Acid Synthase Type I in Replicating Tubercle Bacilli , 2006, Antimicrobial Agents and Chemotherapy.
[134] N. Lall,et al. The potential of South African plants against Mycobacterium infections. , 2008, Journal of ethnopharmacology.
[135] Yashpal Singh,et al. NEURAL NETWORKS IN DATA MINING , 2014 .
[136] N. H. Fischer,et al. New perspectives on natural products in TB drug research. , 2005, Life sciences.
[137] R. Wallace,,et al. Susceptibility testing of slowly growing mycobacteria by a microdilution MIC method with 7H9 broth , 1986, Journal of clinical microbiology.
[138] R. Pompei,et al. Antimycobacterial compounds. New pyrrole derivatives of BM212. , 2004, Bioorganic & medicinal chemistry.
[139] P. Tonge,et al. Inhibiting enoyl-ACP reductase (FabI) across pathogenic microorganisms by linear sesquiterpene lactones from Anthemis auriculata. , 2008, Phytomedicine : international journal of phytotherapy and phytopharmacology.
[140] P. Ortiz de Montellano,et al. Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides. , 2007, Bioorganic & medicinal chemistry.
[141] L. Bekker,et al. Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[142] F. Pavan,et al. Synthesis and in vitro anti Mycobacterium tuberculosis activity of a series of phthalimide derivatives. , 2009, Bioorganic & medicinal chemistry.
[143] P. Hartman,et al. Antibacterial activities of epiroprim, a new dihydrofolate reductase inhibitor, alone and in combination with dapsone , 1996, Antimicrobial agents and chemotherapy.
[144] M. Radi,et al. Synthesis and biological evaluation of new enantiomerically pure azole derivatives as inhibitors of Mycobacterium tuberculosis. , 2009, Bioorganic & medicinal chemistry letters.
[145] G. Besra,et al. Phosphonate inhibitors of antigen 85C, a crucial enzyme involved in the biosynthesis of the Mycobacterium tuberculosis cell wall. , 2004, Bioorganic & medicinal chemistry letters.
[146] A. Bender,et al. In silico target fishing: Predicting biological targets from chemical structure , 2006 .
[147] S. Franzblau,et al. Syntheses and studies of quinolone-cephalosporins as potential anti-tuberculosis agents. , 2006, Bioorganic & medicinal chemistry letters.
[148] A. Vaz,et al. Azole-antifungal binding to a novel cytochrome P450 from Mycobacterium tuberculosis: implications for treatment of tuberculosis. , 2001, Biochemical pharmacology.